4D Molecular Therapeutics, Inc.
FDMT
$6.65
$0.508.13%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 293.23M | 321.44M | 424.88M | 501.89M | 541.95M |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 10.06M | 11.13M | 10.06M | 8.87M | 10.69M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 303.29M | 332.57M | 434.93M | 510.76M | 552.63M |
|
|
|||||
| Total Current Assets | 303.29M | 332.57M | 434.93M | 510.76M | 552.63M |
| Net Property, Plant & Equipment | 37.15M | 39.12M | 40.61M | 41.63M | 29.45M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 9.39M | 7.04M | 4.26M | 2.86M | 2.32M |
| Total Assets | 473.64M | 515.73M | 560.38M | 604.03M | 620.12M |
|
|
|||||
| Total Accounts Payable | 8.70M | 4.15M | 4.39M | 2.92M | 3.43M |
| Total Accrued Expenses | 19.19M | 16.20M | 18.87M | 21.42M | 12.78M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 5.72M | 5.68M | 5.64M | 5.09M | 3.20M |
| Total Finance Division Other Current Liabilities | 1.07M | 866.00K | 257.00K | 35.00K | -- |
| Total Other Current Liabilities | 1.07M | 866.00K | 257.00K | 35.00K | -- |
| Total Current Liabilities | 34.68M | 26.90M | 29.15M | 29.47M | 19.40M |
|
|
|||||
| Total Current Liabilities | 34.68M | 26.90M | 29.15M | 29.47M | 19.40M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 17.36M | 18.17M | 18.97M | 19.74M | 10.46M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 714.00K | 933.00K | 1.66M | 1.87M | 1.91M |
| Total Liabilities | 52.75M | 46.01M | 49.78M | 51.08M | 31.78M |
|
|
|||||
| Common Stock & APIC | 1.10B | 1.09B | 1.09B | 1.08B | 1.07B |
| Retained Earnings | -678.83M | -624.17M | -576.20M | -526.52M | -482.68M |
| Treasury Stock & Other | 337.00K | 332.00K | 229.00K | 1.08M | -293.00K |
| Total Common Equity | 420.89M | 469.72M | 510.61M | 552.95M | 588.34M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 420.89M | 469.72M | 510.61M | 552.95M | 588.34M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 420.89M | 469.72M | 510.61M | 552.95M | 588.34M |
|
|
|||||